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Abstract
Complement activation by anionic liposomes proceeds by antibody-independent, C1q-initiated activation of the classical
pathway. Purified C1q bound to anionic liposomes in an acidic lipid concentration-dependent manner. Saturation binding,
but not the apparent association constant, was enhanced by increasing the cardiolipin content of the liposomes or decreasing
either the pH or ionic strength of the reaction mixture. These observations indicate the involvement of electrostatic factors in
the binding. A highly cationic region in the collagen-like domain of C1q comprised of residues 14^26 of the C1qA
polypeptide chain was assessed for involvement in liposome binding. This region has previously been shown to mediate C1q
binding to other immunoglobulin-independent activators of the classical pathway of complement. Peptides containing
residues 14^26 of C1qA, denoted C1qA14ÿ26, inhibited C1q binding to and complement activation by anionic liposomes. The
inhibitory capacity of these cationic peptides had no sequence or conformation specificity. Rather, the amount of positive
charge on the peptides was the determining factor. When present in excess, peptides with five cationic residues inhibited C1q
binding and complement activation; however, C1q peptides with only two cationic residues did not. In addition to the
C1qA14ÿ26 region, other parts of C1q that contain cationic residues may also be involved in C1q binding to anionic
liposomes. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Liposomes are used for a variety of applications
from serving as model membranes to the delivery of
therapeutic agents. A major limitation to the in vivo
use of liposomes is the fact that in general, injected
liposomes are eliminated from the circulation by the
reticuloendothelial system. Over 90% of neutral lip-
osomes end up in the liver within a few hours of
0005-2736 / 99 / $ ^ see front matter ß 1999 Elsevier Science B.V. All rights reserved.
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Abbreviations: CH, cholesterol; CL, cardiolipin derived from
bovine heart; CL20, liposomes composed of EPC/CH/CL at
35:45:20 mol%; EPC, phosphatidylcholine (PC) derived from
egg; GVB2, gelatin veronal-bu¡ered saline with 0.15 mM
Ca2 and 1 mM Mg2 ; LUV, large unilamellar vesicle ; MLV,
multilamellar vesicle ; VBS, veronal-bu¡ered saline
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injection [1] and certain negatively charged liposomes
are cleared even more rapidly, with half-lives in the
circulation on the order of a few minutes [2]. The
mechanism for the e⁄cient uptake of injected lipo-
somes is believed to involve association with and
opsonization by plasma proteins [3].
Complement proteins are amongst the gamut of
immunoproteins responsible for opsonization and
clearance of foreign particles from the blood. Many
investigators have shown that liposomes can activate
complement, depending on their composition and
physical features (reviewed in [4]). The activation of
complement by liposomes is an important issue as
it can result in loss of liposome stability with sub-
sequent leakage of entrapped substances [5,6] or
liposome opsonization by C3b or iC3b leading to
enhanced uptake by phagocytic cells [7^12]. Comple-
ment activation also results in the release of frag-
ments C3a and C5a. The chemotactic behavior of
these fragments allows for signaling of phagocytic
cells ; Scieszka et al. [8] demonstrated that the gen-
eration of C5a enhanced PMN phagocytosis of lip-
osomes.
In addition to antibody-mediated complement ac-
tivation, anionic liposomes can also initiate comple-
ment in the absence of immunoglobulins, most likely
through the direct binding of C1q [13]. C1q is an
unusually shaped, 465 kDa glycoprotein that consists
of six globular headgroups connected by a triple he-
lix collagen-like stalk [14]. Their are six copies each
of the three distinct polypeptide chains, A, B and C.
The triple helices of the collagen-like region begin
close to the N-terminus of each polypeptide chain
and continue to about residue 89. The remaining
V131 residues of each chain fold to form the glob-
ular head domains [15]. Most C1q normally circu-
lates as part of the C1 complex with two each of
the C1r and C1s subunit proteins in a calcium-de-
pendent association [16]. In the absence of antibody,
C1q binds directly to a variety of substances, includ-
ing a number of di¡erent proteins, polyanions, cell
structures, DNA, and many di¡erent cell types in-
cluding platelets. A group of antibody-independent
complement activators including serum amyloid P
(SAP) [17], C-reactive protein (CRP) [18], DNA
[19], and L-amyloid ¢bers [20] has been shown to
bind the collagenous region of C1q. These activators
share a common property: they all have repeating
negative charges. The speci¢c region of the collage-
nous stalk of C1q that is believed to mediate binding
to this group of activators is contained within the
highly cationic region of residues 14^26 of the
C1qA polypeptide chain [17^20]. Because anionic lip-
osomes have repeating negative surface charges, the
possibility that the C1qA14ÿ26 region of C1q may
play a role in mediating C1q^liposome interactions
was assessed in the present study. The nature of the
interaction between C1q and anionic phospholipids
was also investigated.
2. Materials and methods
Unless otherwise noted, all chemicals were pur-
chased from Sigma Chemicals (St. Louis, MO).
2.1. Puri¢cation and radiolabeling of human C1q
C1q was puri¢ed from fresh acid citrate dextrose-
anticoagulated human plasma obtained from the
Canadian Red Cross Society Blood Services using
the method of Tenner et al. [21] with the following
modi¢cations. Prior to chromatography on BioRex
70 (BioRad, Hercules, CA), serum lipids were re-
moved by centrifugation at 12 500Ug for 30 min at
4‡C. To increase retention of C1q on the column, the
BioRex column was run at pH 7.1 rather than pH
7.3. Fractions containing functional C1q were de-
tected by a C1q ELISA which measures C1q bound
to human IgG-coated wells [13]. Puri¢ed C1q was
stored in 50 mM Tris with 0.5 M NaCl at 380‡C
in 50-Wl aliquots and was used without repeated
freeze^thaw for up to 1 year from the isolation
date. C1q was radiolabeled using the Iodogen meth-
od (Pierce Chemicals, Rockford, IL). The molar ra-
tio of Na125I (Amersham) to C1q was either 1:4 or
1:10, depending on the speci¢c activity desired.
2.2. Peptides
C1qA peptides were synthesized by the Biotechnol-
ogy Protein Service Laboratory, University of British
Columbia. The following peptides were made: au-
thentic C1qA14ÿ26 (A-G-R-P-G-R-R-G-R-P-G-L-
K); C1qAscrambled (K-P-R-G-L-G-G-A-G-R-R-P-
R); C1qAPÿA in which both proline residues were
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replaced with alanine residues (A-G-R-A-G-R-R-G-
R-A-G-L-K); C1qA2 in which three cationic resi-
dues were replaced with glycine residues (A-G-G-P-
G-R-G-G-R-P-G-L-G); and C1qA0 in which all
cationic residues were replaced with glycine residues
(A-G-G-P-G-G-G-G-G-P-G-L-G). A 13-amino-acid
peptide from the terminal sequence of ¢brinogen,
(Fgn) (C-H-H-L-G-G-A-K-Q-A-G-N-V), was used
as a control.
2.3. Preparation of liposomes
Liposomes were made as previously described [22].
Multilamellar vesicles (MLVs) were extruded under
pressure through polycarbonate ¢lters (Costar, Cam-
bridge, MA) (extruder from Lipex Biomembranes,
Vancouver, Canada). Large unilamellar vesicle
(LUV) size distributions were analyzed using the
Nicomp Submicron Particle Sizer (Model 270) (Par-
ticle Sizing Systems, Santa Barbara, CA). Liposomes
extruded through 100-nm pore size ¢lters were
110 þ 20 nm in diameter; liposomes extruded
through 400-nm pore size ¢lters were 240 þ 38 nm
in diameter. The total lipid concentration was deter-
mined from the concentration of phosphate [23] and
the molar ratio of phosphate to the phospholipids.
Phosphatidylcholine (EPC) and cardiolipin (CL)
were purchased from Avanti Polar Lipids (Alabaster,
AL). The liposome composition was EPC/CH/CL at
(353n :45:n mol%). These studies have mainly fo-
cused on compositions containing 20 mol% anionic
phospholipid, as we have previously reported [24]
that there is a signi¢cant increase in complement
activation by compositions containing 20 mol% com-
pared to 10 mol%.
2.4. Equilibrium C1q binding assay
Equilibrium binding measurements were made
with liposomes suspended in bu¡er (1.8 mM sodium
barbital, 3.1 mM barbituric acid, 11% sucrose) with
pure C1q; NaCl concentrations varied from 20 to
145 mM. Reaction mixtures consisted of 15 Wl of
C1q/[125I]C1q mixture, 5 Wl of sucrose-containing
V240 nm liposomes, and 80 Wl of diluting bu¡er.
Liposomes of this size were used in order to achieve
e¡ective separation by the centrifugation method de-
scribed below. To obtain a ¢nal ionic strength of 145
mM NaCl, the dilution bu¡er consisted of 1.8 mM
sodium barbital, 3.1 mM barbituric acid, 77.9 mM
NaCl, and 7.2% D-glucose. Following a 20-min reac-
tion at room temperature (RT) (results were time-
independent for 1 to 60 min), 40 Wl of reaction mix-
ture was layered onto 180 Wl of an intermediate den-
sity separating bu¡er (1.8 mM sodium barbital, 3.1
mM barbituric acid, 4.5% sucrose, 2.9% D-glucose,
and 145 mM NaCl) in 5U20 mm polyallomer tubes.
Tubes were centrifuged for 30 min at 166 300Ug to
pellet s 90% of the liposomes, frozen, then sliced
into two pieces: a pellet slice containing liposome-
bound C1q and a supernatant slice. Tube slices were
counted in an LKB Wallac gamma counter (Compu-
gamma model 1282). Tubes containing C1q but no
liposomes were run in parallel (C1q control). The
amount of [125I]C1q spun down in this control tube
was always less than 8% and was subtracted from the
binding values for the liposome/C1q reaction tubes.
The amount of C1q bound to liposomes was calcu-
lated as follows:
Wg C1q bound  cpmpellet3cpmC1qcontrol=
specific activity of C1q mixture 1
2.5. Inhibition of C1q binding to anionic liposomes by
peptides
To measure the inhibition of C1q binding to lip-
osomes by C1qA peptides, peptides were mixed with
liposomes and [125I]C1q in bu¡er and binding was
measured as in Section 2.4. Reaction mixtures con-
sisted of 74 Wl diluting bu¡er, 15 Wl of C1q/[125I]C1q
mixture, 5 Wl of sucrose-containing 240-nm lipo-
somes, and 6 Wl of peptide or peptide bu¡er. The
percent inhibition of C1q binding was calculated as
follows:
% inhibition  1003C1qboundCL20lipopeptide=
C1qboundCL20U100 2
where C1qbound = (% of cpm in pellet)sample3(% of
cpm in pellet)C1q control
2.6. Functional complement assay
The capacity of C1q peptides to inhibit comple-
ment activation by anionic liposomes was measured
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in a modi¢ed hemolytic assay. Liposomes (V100 nm
in diameter) were suspended in isotonic veronal-bu¡-
ered saline (VBS: 1.8 mM sodium barbital, 3.1 mM
barbituric acid, 145 mM NaCl, pH 7.4). These stud-
ies were performed using 100-nm vesicles since ex-
truded liposomes of this size and composition have
little or no multilamellar character, allowing better
estimates of exposed surface area. Normal human
serum (NHS) was prepared from venous blood col-
lected from healthy donors and stored at 380‡C.
Peptides were ¢rst serially diluted in VBS containing
0.15 mM CaCl2, 1 mM MgCl2, and 0.1% gelatin
(GVB2). An equal volume of EPC/CH/CL
(35:45:20 mol%) liposomes (5 mM) was added to
the peptides and the mixture was incubated at RT
for 40 min. An equal volume of NHS diluted 1:4 in
GVB2 was then added to each tube. After 30 min at
37‡C, three volumes of GVB2 were added to the
serum/liposome mixture. Controls consisted of a col-
or blank (liposomes incubated with bu¡er and with-
out serum), a 100% lysis control (serum incubated in
the absence of liposomes or peptides), a CL20 lip-
osome control (liposomes with serum and no pepti-
des), and peptide controls (peptides with serum and
no liposomes).
The total residual complement content of the lip-
osome-treated serum was then measured by adding
antibody sensitized sheep red blood cells (EA cells)
to the liposome/serum mixture as previously de-
scribed [13]. The level of EA lysis for CL20 liposome
control tubes was only slightly higher than the EA
lysis in the color blanks indicating that virtually all
of the complement in these tubes was activated by
the liposomes in the absence of peptides. The percent
inhibition of complement activation was equivalent
to the percent EA lysis and was calculated as fol-
lows:
% inhibition of activation 
A415 for test sample3Acolor blank=
A415 for 100%3Acolor blankU100 3
2.7. Particle electrophoresis
Particle electrophoresis permits direct microscopic
observation of the behavior of individual liposomes
in an electric ¢eld by the use of a water immersion
objective and a quartz cylindrical electrophoresis
chamber (Rank Mark I, Rank Bros, Bottisham,
UK). The method may be used to provide a direct
calculation of the zeta potential without the artifacts
that may be introduced into other techniques such as
laser Doppler by the particles themselves. In order to
visualize the liposomes, this method requires the use
of MLVs. To assess the interaction of C1q or C1q
peptides with liposomes, MLVs at 0.36 mM total
lipid in 1.8 mM sodium barbital, 3.1 mM barbituric
acid, with either 20 mM, 100 mM, or 145 mM NaCl,
pH 5.0 or 7.0, were pre-incubated with C1q or pep-
tides for 40 min at RT in a total volume of 780 Wl.
Just prior to £ooding the electrophoresis chamber
with the reaction mixture, the same bu¡er was added
to bring the mixture volume to 2.8 ml. C1q or C1q
peptide binding to liposomes was then monitored as
described previously [25]. Ten or more particles were
timed per experimental condition as they moved
across the eyepiece reticule. The mobility was calcu-
lated from the averaged velocities, the applied volt-
age, and the chamber electrical length according to
the following calculation [26]:
electrophoretic mobilityW 
particle velocity Wm=s=
electric field strength E V=cm 4
where E = (voltage/l) and l = the e¡ective distance
between the electrodes.
3. Results
3.1. The e¡ect of liposome surface charge density on
C1q binding
Quantitative measurements of C1q binding to lip-
osomes were made using the C1q equilibrium bind-
ing assay. No C1q binding to neutral EPC/CH
(55:45 mol%) liposomes was detected. C1q binding
to anionic liposomes depended upon the amount of
anionic phospholipid. As the anionic phospholipid
content increased, a concomitant increase in the
amount of C1q binding to liposomes was observed
(Fig. 1). While increasing cardiolipin from 20 mol%
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to 30 mol% resulted in a 4-fold increase in the
amount of C1q binding at saturation, doubling the
cardiolipin content resulted in 40-times more C1q
binding (Table 1). Each data set was ¢t to the fun-
damental binding (Langmuir) equation:
Y  P1 P2 X=1 P2 X 5
where Y = amount of C1q bound/Wmol of lipid,
P1 = saturation level of binding, P2 = association
constant (1/M) and X = C1q concentration (M).
Data sets were ¢t utilizing the non-linear least
squares procedure in Origin (Microcal). Fig. 1 illus-
trates the data (points) and the best ¢t curves (solid
lines). The parameters of best ¢t for each set are
given in Table 1. In all cases the data ¢t the above
equation satisfactorily over the whole range of con-
centration examined.
3.2. E¡ect of ionic strength and pH on C1q^liposome
binding
Since the importance of electrostatics was implied
by the dependence of C1q binding on liposome sur-
face charge, the e¡ects of ionic strength and of pH
on C1q binding were investigated. C1q^CL20 lipo-
some interactions were monitored at pH 5.0 and pH
7.0 by particle electrophoresis under di¡erent ionic
strength conditions (Fig. 2). It is important to note
that the electrophoretic mobilities re£ect the extent
of C1q^liposome interactions, but the method does
not allow for quantitative interpretation of the
amount of C1q bound to the liposomes. The mobi-
lities of MLVs without C1q decreased as the ionic
strength went from 20 mM NaCl up to 145 mM, as
expected. Liposome mobilities were identical at pH 5
and pH 7. When C1q was reacted with CL20 MLVs,
the mobility shifted towards zero as C1q binding to
MLVs decreased the liposome surface charge. The
magnitude of the liposome mobility shift after incu-
bation with C1q was inversely related to ionic
strength; CL20 MLVs bound more C1q at lower
Fig. 1. C1q binding to cardiolipin-containing liposomes: e¡ect
of surface charge density. C1q binding to 240 nm liposomes at
pH 7.2 was measured using the C1q equilibrium binding assay.
Liposomes were composed of EPC/CH/CL at (553n) :45:n mol
% where n = 0 (O), 20 (F), 30 (E), or 40 (R) mol% of CL. The
solid lines are plots of the equation given in the text utilizing
the best ¢t values for the parameters given in Table 1. A con-
stant total lipid concentration of 0.5 mM was used in the reac-
tion. Because far greater levels of C1q binding were measured
for CL40 liposomes, the vertical axis is presented in log scale.
Most data points for EPC/CH liposomes (O) were zero; these
are not shown due to the log scale.
Table 1
Apparent association constants and saturation values for C1q binding to liposomes: e¡ect of liposome surface charge density





EPC/CH/CL (35:45:20) 6.4U10314 4.5U108 þ 0.8U108 2.2U1036 þ 9.8U1038 3/2
EPC/CH/CL (25:45:30) 1.3U10313 5.1U108 þ 1.0U108 6.6U1036 þ 4.0U1037 5/1
EPC/CH/CL (15:45:40) 1.0U10311 4.7U108 þ 0.6U108 6.0U1035 þ 2.3U1036 50/1
Saturation binding and association constants for CL20, CL30 and CL40 liposomes were derived from the non-linear least-squares ¢t
and are reported with the estimate of standard error (E.S.E.). To convert Wmol total lipid to number of vesicles, the surface area per
vesicle and the number of vesicles per Wmol total lipid were ¢rst estimated. The surface area per vesicle was calculated as
SAvesicle = 4Zr2 and was 1.8U1039 cm2/vesicle for our system. The number of 240 nm vesicles per Wmol total lipid was estimated to be
8.0U1011 vesicles/Wmol lipid, assuming that 35% of the total lipid is exposed [28] and that the average area per lipid is 0.7 nm2.
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ionic strength. This trend was observed whether the
pH was 5 or 7 but was more pronounced at pH 7.
When C1q was added at pH 7, liposome mobilities
decreased more than 5 mobility units at 20 mM
NaCl but did not change at 145 mM NaCl. C1q
had larger e¡ects on the mobilities of CL20 MLVs
at pH 5 than at pH 7 under every ionic strength
condition tested.
While liposome mobilities were being measured,
the aggregation state of the liposomes was moni-
tored. Liposome aggregation was observed under
conditions where C1q binding to anionic liposomes
was enhanced, at low ionic strength (20 mM NaCl)
and at low pH (pH 5.0). At pH 7 and 145 mM NaCl,
no aggregation was observed.
3.3. Inhibition of C1q binding to CL20 liposomes by
C1qA peptides
C1qA, C1qA-control, and unrelated peptides were
examined for their ability to compete with C1q in the
C1q equilibrium binding assay (Fig. 3A). At 240 WM,
the C1qA14ÿ26 authentic peptide completely blocked
CL20^C1q binding; at 50 WM, 70% of C1q binding
was inhibited. C1qA control peptides, C1qAscrambled
and C1qAPÿA, also inhibited C1q binding to CL20
liposomes suggesting that a peptide conformational
or sequence speci¢city was not required. The charge
control peptides, C1qA0 and C1qA2, did not
inhibit C1q^CL20 binding, indicating that more
Fig. 2. Ionic strength and pH dependence of C1q binding to
CL20 MLVs. Particle electrophoresis was carried out on CL20
MLVs alone (open symbols) or in the presence of C1q (closed
symbols) under di¡erent NaCl concentration conditions at pH
5 (O,R) and 7 (a,b). Where liposomes were preincubated with
C1q, the total lipid in the reaction was 0.36 mM and the C1q
concentration was 0.134 mM (61.5 Wg/ml). The complete experi-
ment was carried out twice; one data set is shown by the solid
lines and the other by the dotted lines. Error bars represent
one standard deviation of the mean of the mobilities of the ten
vesicles. Where no error bars are shown, one S.D. was smaller
than the size of the symbol used for the mean.
Fig. 3. C1qA peptides inhibit C1q binding to and complement
activation by CL20 liposomes. C1q binding to CL20 liposomes
in the presence of peptides at pH 7.2 was measured using the
C1q equilibrium binding assay (panel A). The reaction mixture
consisted of 0.5 mM total lipid, 9 nM C1q, and peptides at dif-
ferent concentrations. The amount of complement consumed
(activated) by CL20 liposomes (5 mM) in human serum (diluted
1:4) after an initial incubation of liposomes and peptides was
measured using a modi¢ed hemolytic assay (panel B). The per-
cent inhibition of C1q binding (panel A) or complement activa-
tion (panel B) is shown for the authentic C1qA14ÿ26 (R),
C1qAscrambled (a), C1qAPÿA (P), C1qA0 (E), C1qA2
(O), and the unrelated Fgn (W) peptides. Data points show the
mean of three experiments. Error bars represent one standard
deviation. Where no error bars are shown, one S.D. was small-
er than the size of the symbol used for the mean.
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than two cationic residues were required to interact
with anionic liposomes. The role of the amino termi-
nal charge in the peptides was not directly assessed;
however, since C1qA0 had no e¡ect on binding, it
is unlikely that the amino terminal charge of the
peptides plays a signi¢cant role. One peptide,
C1qAscrambled, was also prepared with a blocked
carboxy terminal. Its ability to block C1q binding
was una¡ected by this modi¢cation (data not
shown). Surprisingly, the unrelated Fgn peptide at
240 WM inhibited 70% of C1q binding to CL20 lip-
osomes.
3.4. Inhibition of liposome complement activation by
C1qA peptides
A modi¢ed hemolytic assay was used to measure
the ability of C1qA and control peptides to inhibit
complement activation by liposomes in human serum
(Fig. 3B). C1qA14ÿ26 completely blocked comple-
ment activation by CL20 liposomes at a concentra-
tion of 3 mM in this system and produced 40% in-
hibition at approximately 1.7 mM. Control C1qA
peptides (scrambled and P-A peptides) inhibited
complement activation to the same extent as the au-
thentic peptide verifying that the interaction lacks
sequence and conformational speci¢city. Charge con-
trol peptides, C1qA0 and C1qA2, failed to in-
hibit complement activation by CL20 liposomes con-
¢rming that more than two positively charged
residues are required for e¡ective interaction of
C1q with anionic liposomes. The unrelated Fgn pep-
tide failed to inhibit complement activation. Peptides
incubated with EA cells alone did not cause cell lysis
and peptides incubated with NHS in the absence of
liposomes did not activate complement.
3.5. Direct interaction of cationic peptides with
anionic liposomes
The direct interaction between anionic liposomes
and C1q peptides was assessed by particle electro-
phoresis at pH 7 under interaction-promoting low
ionic strength conditions (Fig. 4). Authentic
C1qA14ÿ26, C1qAscrambled, and C1qAPÿA peptides
all interacted strongly with CL20 MLVs. In contrast,
no interaction was detected with the C1qA0 pep-
tide. While some peptide^MLV binding was ob-
served at the highest concentration of the C1qA2
peptide (900 Wg/ml), it was less than the Fgn peptide.
The magnitude of these direct interactions between
C1qA peptides and CL20 MLVs mirrored the inhib-
itory capacities of the peptides.
To further characterize peptide^CL20 MLV inter-
actions, the e¡ect of ionic strength was investigated
using particle electrophoresis. Mobility measure-
ments were made on ten vesicles in the mix-
ture each time in 3 complete experiments. CL20
MLVs alone had mobilities of 35.94 þ 0.18 and
33.48 þ 0.17 (Wmccm/Vcs þ S.D.) in 20 mM and 100
mM NaCl, respectively. When peptides (90 Wg/ml)
were incubated with CL20 MLVs, a mobility shift
towards zero indicated that peptide binding to lip-
osomes had occurred. C1qA14ÿ26 and the sequence
and conformation control peptides, C1qAscrambled
and C1qAPÿA, exhibited a high level of lipo-
some binding with more binding at lower ionic
strength. Liposome mobilities in 20 mM NaCl
were 31.06 þ 0.11, 31.49 þ 0.08, and 31.33 þ 0.03
(Wmccm/Vcs) for C1qA14ÿ26, C1qAscrambled and
C1qAPÿA respectively. In 100 mM NaCl, mobilities
Fig. 4. Interaction of C1qA peptides with CL20 liposomes. Par-
ticle electrophoresis was used to monitor the direct interaction
of C1qA and control peptides with CL20 MLVs at pH 7 and
20 mM NaCl. Peptides at 9, 45, 90, or 900 Wg/ml were incu-
bated with MLVs (0.36 mM total lipid in reaction) for 40 min
at room temperature. Liposome mobilities in the presence of in-
creasing amounts of C1qA14ÿ26 (R), C1qAscrambled (a),
C1qAPÿA (P), C1qA0 (E), C1qA2 (O), and unrelated
Fgn (W) peptides are presented. Mobility measurements were
made on ten vesicles in the mixture each time. The complete ex-
periment was carried out three times. Error bars represent one
standard deviation. Where no error bars are shown, one S.D.
was smaller than the size of the symbol used for the mean.
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were 31.74 þ 0.11, 31.95 þ 0.06, and 31.68 þ 0.09
(Wmccm/Vcs) for these peptides. While C1qA0
and C1qA2 peptides did not bind to CL20
MLVs, the Fgn peptide exhibited a slight binding
capacity but only at 20 mM NaCl (liposome mobi-
lity: 35.05 þ 0.13 (Wmccm/Vcs)).
At pH 7, liposomes aggregated under conditions
where C1qA peptide binding was enhanced: at low
ionic strength and when highly charged peptides were
used. Even at 20 mM NaCl, when C1q(0+) or Fgn
peptides were used, no aggregation was observed.
For the highly charged peptides, the authentic
C1qA14ÿ26, C1qAscramble, and C1qAPÿA, liposome
aggregation was proportional to the amount of pep-
tide added.
The techniques employed in these studies necessi-
tated using liposomes of di¡erent size. Our earlier
studies of the e¡ects of liposome composition on
complement activation were carried out using unila-
mellar 100-nm vesicles [24,27]; however, this size of
liposomes could not be used for either the equili-
brium binding studies or the particle electrophoresis
studies. It is possible that the ¢ndings are somewhat
in£uenced by liposome size. We have previously
demonstrated that for a constant amount of phos-
pholipid, larger vesicles (V260 nm) are more e¡ec-
tive complement activators than smaller vesicles (70
nm) [27]. Thus, we may have underestimated the
amount of C1q binding in functional complement
assays relative to that measured in equilibrium bind-
ing studies.
4. Discussion
Anionic liposomes can activate the classical path-
way of complement in either an antibody-dependent
or in an antibody-independent manner [13,24]. Since
complement activation may lead to the rapid loss of
liposomes in the blood, we wished to gain a better
understanding of the factors involved in the direct
binding of C1q to anionic liposomes.
Under physiologic pH and ionic strength, a small
but measurable amount of C1q bound to anionic
liposomes. The saturation binding value for CL20
liposomes was 2.2U1036 Wmol C1q bound per
Wmol of total lipid or 3 C1q molecules for every
two liposomes. This low level of binding of C1q
was somewhat surprising since these liposomes have
been previously shown to strongly activate comple-
ment in a full complement activation assay [13].
Others have made related comparisons, however.
Kovacsovics et al. [28] found that C1 activation
was more readily detected than C1q binding. In gen-
eral, the binding of small amounts of C1q to activa-
tor surfaces still results in an irreversible activation
event. Also, the cascade nature of complement acti-
vation allows for a greater complement response
than the level of C1q binding might appear to war-
rant.
While C1q binding was small at physiologic pH
and ionic strength, the binding capacity was en-
hanced by increasing the surface charge density of
the anionic liposomes. As the proportion of anionic
phospholipid in the liposomes increased, increases in
C1q binding at saturation were measured (Fig. 1,
Table 1). This relationship between surface charge
density and C1q binding parallels the e¡ect of
anionic phospholipid concentration on overall com-
plement activation reported in several studies
[1,24,27]. Our results con¢rm and expand upon ob-
servations by Kovacsovics et al. [28] of the charge
density dependence of C1q binding and activation of
C1 by cardiolipin-containing liposomes.
The fact that liposome surface charge density
strongly a¡ects the level of C1q binding to liposomes
indicates that electrostatic attraction is necessary for
C1q to bind to liposomes. Negative cooperativity,
i.e., a decrease in apparent association constant as
binding proceeds, would be expected since the sur-
face charge on the liposome decreases as ligand bind-
ing proceeds. However, this was not observed as the
data sets all ¢t the simple binding equation satisfac-
torily with a single association constant. Moreover,
while the saturation level of C1q binding increased
with increasing CL, the association constant was in-
dependent of the concentration of charged lipid in
the liposomes (Table 1). This is opposite to what is
expected for a purely electrostatic model in which the
electrostatic attraction can strongly enhance the ap-
parent association constant [29]. This may suggest
that the physical binding of C1q to the liposome
surface relies on hydrophobic interactions as well
as electrostatic ones and that the binding reaction
is not as simple as implied by the equation utilized
to ¢t the individual data sets. De Kroon [30] has
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suggested that both electrostatic and hydrophobic
forces are involved in the binding of positively
charged peptides to CL-containing vesicles.
The e¡ects of ionic strength and pH on C1q^lip-
osome interactions were assessed using particle elec-
trophoresis. The electrophoretic mobility of a par-
ticle is measured as the velocity of a vesicle in an
applied electric ¢eld and is directly related to the
surface charge density of the liposome [31]. When
C1q was added, the binding of C1q to liposomes
decreased the magnitude of the liposome electropho-
retic mobility by masking liposome surface charge
and replacement by exposed charges on the lipo-
some-bound proteins. Consequently, the decrease in
liposome electrophoretic mobility is directly related
to the amount of C1q bound. It is important to note
that due to the experimental design for particle elec-
trophoresis studies, C1q^liposome interactions may
be underestimated by these measurements. To con-
serve puri¢ed C1q, the reaction mixture volume was
kept at 780 Wl, then diluted with bu¡er to ¢ll the 2.8-
ml sample chamber. Dilution immediately prior to
making the electrophoretic mobility measurements
may have displaced some C1q from the liposomes.
This dilution e¡ect probably explains why C1q bind-
ing to MLVs at physiologic pH and the ionic
strength seen in the equilibrium binding assay was
not detected by particle electrophoresis.
A much greater relative change in the electropho-
retic mobility of the liposomes was observed in the
presence of C1q as the ionic strength was lowered
from physiologic 145 mM to 20 mM, re£ecting en-
hanced C1q binding to CL20 MLVs as the ionic
strength was decreased. The enhancement of C1q
binding by lowering the ionic strength was antici-
pated since many studies of C1q binding to other
substances utilized low ionic strength conditions
[32^35]. Even C1q binding to speci¢c receptors on
cells and platelets is ionic strength dependent [36].
C1q binding to anionic liposomes was also highly
dependent upon the pH of the environment with
more C1q binding at pH 5 than at pH 7. The en-
hancement of protein binding to anionic liposomes
by decreasing the pH has been reported for other
proteins [30,37]. With respect to electrostatics, C1q
recruitment to the liposome surface by attraction be-
tween membrane- and protein-associated charges
would be strongest at low pH.
The aggregation state of C1q may also contribute
to the di¡erent binding levels at decreased ionic
strength and pH. Aggregated C1q would be expected
to bind more strongly due to multivalent interactions
with liposomes. C1q aggregation occurs when the
ionic strength is reduced below 100 mM NaCl [38]
and is implied here by the observation that liposomes
aggregated under conditions where higher levels of
C1q binding occurred (low pH and low ionic
strength). Liposome aggregation may be mediated
by C1q aggregation although the reduced liposome
surface potential as a result of C1q binding will also
contribute.
We examined a candidate region of C1q which
could mediate the interaction of C1q with anionic
liposomes: residues 14^26 within the collagen-like
region of the C1qA chain. As described for the anti-
body-independent complement activators, SAP,
CRP, DNA and L-amyloid, C1qA14ÿ26 peptide
was capable of completely inhibiting C1q binding
and complement activation by anionic liposomes
[17^20]. Inhibition of C1q binding to anionic lipo-
somes required the same relative amount of
C1qA14ÿ26 peptide as that required for inhibition
of C1q binding to CRP or to DNA. However, this
amount is very large; a molar ratio of 1.8U104 :1
(peptide:C1q) was needed to inhibit C1q binding
by 90%. Similar ratios have been reported by others
[19]. High concentrations of peptides may be re-
quired to outcompete C1q since C1q may contain
six or more binding sites.
In marked contrast to studies on other direct com-
plement activators [17^19], the capacity of the
C1qA14ÿ26 peptide to inhibit C1q binding and
complement activation by anionic liposomes lack-
ed any sequence or conformational speci¢city.
C1qAscrambled and C1qAPÿA peptides exhibited
the same inhibitory abilities as the authentic
C1qA14ÿ26 peptide. In addition, all three peptides
interacted directly with anionic liposomes to virtually
the same extent. Thus, C1q binding and complement
activation on a phospholipid membrane di¡ers from
binding and activation by protein, DNA or ¢ber ag-
gregates.
The lack of sequence and conformation speci¢city
in the interaction between C1q and anionic lipo-
somes indicates that the charge component was of
prime importance. Only peptides with a large net
BBAMEM 77573 2-4-99
A.J. Bradley et al. / Biochimica et Biophysica Acta 1418 (1999) 19^30 27
positive charge (+5) were capable of interacting with
anionic liposomes and inhibiting C1q binding and
complement activation. Peptides with two cationic
charges bound slightly at very low ionic strength,
not at all in 100 mM NaCl and had no inhibitory
e¡ects. For the neutral peptide (C1qA0), no bind-
ing to liposomes and no inhibitory capacity was de-
tected. In addition, the inverse relationship between
ionic strength and C1qA peptide^liposome binding
mirrored the ionic strength dependence shown for
C1q^liposome binding (Fig. 2) and for C1q^DNA
interactions [19]. The unmodi¢ed peptide sequence
is derived from a collagen-like region in the C1q
A-chain. If one aligns the peptide sequence in a col-
lagen helix (n = 3 residues per turn), the peptide
shows the classical collagen alignment of all glycine
residues to form an apolar side to the helix and pro-
line residues aligned on a second side. The third side
of the helix contains three of the ¢ve cationic resi-
dues. Although this alignment, especially of the gly-
cine residues, is thought to facilitate collagen’s terti-
ary and quaternary structure, it is unlikely to be the
major factor in peptide inhibition of C1q binding.
The alignment of the scrambled sequence places cat-
ionic residues on all sides of a collagen helix, yet the
scrambled peptide e¡ectively inhibited C1q binding
to anionic liposomes.
Since C1qA peptides of su⁄cient charge (possibly
more than two and certainly ¢ve cationic residues)
were capable of successfully inhibiting C1q-mediated
complement activation by anionic liposomes regard-
less of the primary sequence or conformation of the
peptide, other regions of the protein with a similar
expanse of residues may also be involved. Another
cationic region of the C1qA chain, residues 76^92 at
the hinge region of the structure, is of secondary
importance in mediating the binding of C1q to
DNA [19], to CRP trimers [18] and to SAP trimers
[17]. Residues 76^92 include four cationic amino
acids and one anionic residue, giving a net charge
at physiologic pH of +3. This region is therefore a
candidate site on C1q for an electrostatic interaction
with anionic liposomes.
Partial inhibition of C1q binding to anionic lipo-
somes by the Fgn peptide (having an overall charge
of approximately +1.2 at pH 7.2) was unexpected.
The Fgn peptide neither bound anionic MLVs at
100 mM NaCl nor inhibited complement activation
indicating that the mechanism by which the Fgn pep-
tide blocked C1q^liposome binding was di¡erent
from that of C1qA peptides. Fibrinogen binds di-
rectly to C1q through at least two sites: one each
on the collagenous and the globular regions [32].
The Fgn peptide may bind to C1q near the liposome
binding site and thus interfere with C1q^liposome
binding. The failure of the Fgn peptide to block
complement activation by anionic liposomes may
be due to alteration of the C1q^Fgn peptide interac-
tion by other serum proteins.
These experiments characterizing the binding of
C1q to anionic liposomes collectively have shown
that electrostatics play a dominant role in the inter-
action between C1q and liposomes. C1q^liposome
binding depended on liposome surface charge and
on the pH and ionic strength of the environment.
In addition, competitive C1q binding and comple-
ment activation experiments with peptides at physio-
logic pH and ionic strength as well as direct measure-
ments of peptide^liposome interactions identi¢ed the
electrostatic component of the C1q^liposome inter-
action as being important. However, other chemical
forces including hydrophobic interactions may also
contribute to the actual binding energy.
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